Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

1.61
Delayed Data
As of 3:59pm ET
 +0.05 / +3.21%
Today’s Change
0.64
Today|||52-Week Range
4.24
-39.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-51.5M-69.2M-78.0M-70.5M
 
 
 
 
 
Depreciation1.4M941.0K465.0K594.0K
 
 
 
 
 
Total Other Cash Flow7.3M8.2M5.4M6.9M
 
 
 
 
 
Funds From Operations-42.7M-60.1M-72.1M-62.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-19.3M15.8M5.4M-4.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-23.4M-75.9M-77.6M-58.8M
 
 
 
 
 
 
InvestingIncrease In Investments-151.8M-103.1M-116.9M-78.0M
 
 
 
 
 
Decrease In Investments196.9M128.7M96.8M104.1M
 
 
 
 
 
Capital Expenditures-546.0K-804.0K-164.0K-1.1M
 
 
 
 
 
Fixed Asset Disposal60.0K88.0K732.0K0.00
 
 
 
 
Net Cash Flow Investing44.6M24.9M-19.5M25.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale7.1M25.2M117.7M71.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing7.1M25.2M117.7M71.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash28.3M-25.8M20.7M38.0M